Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Alzheimer's Association of Israel
InstitutionResearch output, impact & collaborations
Alzheimer's Association of Israel is a research organisation in Ramat Gan, IL. OpenAlex records 1,251 works and 57,691 citations for it. 505 researchers list it as their most recent affiliation.
1,251
Works
57,691
Citations
505
Researchers
56
Avg h-index
How has Alzheimer's Association of Israel's publication output changed over time?
ScholarIQpublication output · 2013–2020
Output grew0% over the shown period — from 1 works in 2013 to 1 in 2020.
1
1
1
3
5
1
201320142017201820192020
Who are the most-cited researchers behind Alzheimer's Association of Israel?
ScholarIQtop researchers by citations
What are the most-cited papers on Alzheimer's Association of Israel?
ScholarIQmost cited works
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Michael G. Silverman, Thomas A. Zelniker, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Christian T. Ruff, Ingrid Gause‐Nilsson, Martin Fredriksson, Peter A. Johansson, Anna-Maria Langkilde, Marc S. Sabatine
New England Journal of Medicine. 20186,387 CitationsOPEN ACCESS
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald, Philippe Gabríel Steg, Jaime A. Davidson, Boaz Hirshberg, Peter Öhman, Robert Frederich, Stephen D. Wiviott, Elaine Hoffman, Matthew A. Cavender, Jacob A. Udell, Nihar R. Desai, Ofri Mosenzon, Darren K. McGuire, Kausik K. Ray, Lawrence A. Leiter, Itamar Raz
New England Journal of Medicine. 20133,486 CitationsOPEN ACCESS
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, KyungAh Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Remo H.M. Furtado, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Marc S. Sabatine
The Lancet. 20182,848 Citations
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G. Eliaschewitz, Denise Reis Franco, Ole Kleist Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D. Pedersen, Cees J. Tack, Mette S. Thomsen, Tina Vilsbøll, Mark Warren, Stephen C. Bain
New England Journal of Medicine. 20191,969 CitationsOPEN ACCESS
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Patrick M. O’Neil, Andreas L. Birkenfeld, Barbara McGowan, Ofri Mosenzon, Sue D. Pedersen, Sean Wharton, Charlotte Giwercman Carson, Cecilie H. Jepsen, Maria Kabisch, John Wilding
The Lancet. 2018813 Citations
How much of the research on Alzheimer's Association of Israel is open access?
ScholarIQopen access share
58%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
58%
Closed
42%